CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Analyst Ratings
NASDAQ:CNTB - Nasdaq - US2075231017 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to CNTB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 511.94% above the current price.
CNTB was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CNTB.
In the previous month the buy percentage consensus was at a similar level.
CNTB was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Initiate | Buy |
| 2023-09-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-02-08 | SVB Leerink | Maintains | Outperform |
| 2022-06-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-05-05 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-05-04 | SVB Leerink | Maintains | Outperform |
| 2022-01-06 | SVB Leerink | Maintains | Outperform |
| 2021-07-02 | CICC | Initiate | Outperform |
| 2021-04-13 | SVB Leerink | Initiate | Outperform |
| 2021-04-13 | Jefferies | Initiate | Buy |